
New therapies on the horizon offer options for slowing progression

First new therapy in nearly a decade offers another option for physicians, patients


Patient enrollment for the NORSE 2 clinical trial has been completed, with safety and efficacy data expected to be reported in the third quarter of 2021.

Research is seeking benefits, options for open-angle glaucoma patients

Novel technologies range from invasive to non-invasive approaches

Medical practitioners face emotional burden, other hurdles from pandemic

The American Medical Association, American Hospital Association and American Nurses Association on Monday urged Americans to wear a mask and practice social distancing in an effort to stem the spread of the coronavirus.

Patient expectations continue to push clinicians to look at optimal ways to arrive at the best IOLs.

Bonuses are the norm and not risked by pass-through medication use

In Australia, residents of suburbs of the city of Melbourne that are considered COVID-19 hot spots are being visited in their homes by authorities

Alternative method ensures lens is set properly during cataract surgery

In a new survey by medical software provider Kyruus, nearly three quarters had tried virtual care during the COVID-19 pandemic and more than 75 percent said they were very or completely satisfied with their experience.

Details help pave way for clinicians to provide safe environments for their patients


A survey from The Larry A. Greene Center and the Primary Care Collaborative found that the COVID-19 pandemic is impacting the well-being of physicians.

Maximizing refractive surgery is key to ensuring prosperous future

According to the Centers for Disease Control, coronavirus cases are on the rise in at least 32 states, and many of these states are also seeing increasing hospitalizations. These numbers are raising a red flag among ophthalmologists.

The CDC has updated the COVID-19 symptom list to include congestion or runny nose, nausea or vomiting, and diarrhea.

A report out of the United Kingdom revealed more than a 70% reduction in new referrals and a high rate of missed appointments due to the coronavirus, raising red flags for U.S. ophthalmologists.

Treatment options may expand beyond surgery, medication, and lasers

Overcoming protein deficiency in autosomal dominant optic atrophy

Subclinical lesions have been detected that are not apparent on other imaging platforms



The leadership of the American College of Physicians and the American Medical Association, in a joint letter issued this week, are calling for the U.S. healthcare system to wake up to the inequities laid bare by the COVID-19 pandemic.

A team of researchers at the University of Alberta believe a case of pink eye is now a reason to be tested for COVID-19.


The North American Neuro-Ophthalmology Society, in alliance with the Spencer S. Eccles Health Sciences Library at the University of Utah, is offering the Neuro-Ophthalmology Virtual Education Library.
